Subscribe free

Metabolic and Bariatric Surgery ·

Sleeve Gastrectomy Outperforms Semaglutide for Weight Loss

In a study comparing weight loss outcomes between sleeve gastrectomy (SG) and semaglutide in a minority population, SG demonstrated superior weight loss after 12 months. The cohort, primarily consisting of African American (67%) and Hispanic (21%) patients with a mean BMI of 55 kg/m², included 206 participants. Results indicated that semaglutide may be less effective for those with severe obesity, highlighting a need for further research into the efficacy of GLP-1 agonists in diverse populations.

Journal Article by Masrur MA, Manueli Laos EG (…) Schlottmann F et 3 al. in Obes Surg

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Obes Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →